drugset / Trial / NCT00354432

Soy Protein/Effexor Hormone Therapy for Prostate Cancer

NCT00354432

RandomizedFactorialQuadruple-blindSupportive care

Summary

RATIONALE: Soy protein/isoflavones and venlafaxine may help relieve hot flashes in patients receiving hormone therapy for prostate cancer. It is not yet known whether soy protein/isoflavones are more effective than venlafaxine when given together or with a placebo in treating hot flashes. PURPOSE: This randomized phase III trial is studying soy protein/isoflavones and venlafaxine to compare how well they work when given together or with a placebo in treating hot flashes in patients receiving hormone therapy for prostate cancer.

Timeline

Start
2007-02-01
Primary completion
2010-08-01
Completion
2010-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Venlafaxine Small molecule 75 mg Oral

Indications